Study | Country | Recruitment period | Study design | Cases N | Controls N | ||||
---|---|---|---|---|---|---|---|---|---|
men | women | total | men | women | total | ||||
Case–control studies | |||||||||
Los-Angeles bladder cancer Case–control study [10] | USA | 1987–1999 | Population based case–control | 1,307 | 353 | 1,660 | 1,237 | 349 | 1,586 |
Roswell Park Cancer Institute [11] | USA | 1982–1998 | Hospital-based case–control | 164 | 53 | 217 | 501 | 163 | 664 |
Belgian Case–control study on bladder cancer [12] | Belgium | 1999–2004 | Population based case–control | 172 | 28 | 200 | 228 | 156 | 384 |
Aichi Prefecture Case–control study [13] | Japan | 1996–1999 | Hospital-based case–control | 245 | 58 | 303 | 244 | 59 | 303 |
Kaohsiung [14] | Taiwan | 1996–1997 | Hospital-based case–control | 31 | 9 | 40 | 124 | 36 | 160 |
Hessen Case–control study on bladder cancer [15] | Germany | 1989–1992 | Hospital-based case–control | 239 | 61 | 300 | 239 | 61 | 300 |
Stockholm Case–control study [16] | Sweden | 1985–1987 | Population based case–control | 204 | 67 | 271 | 281 | 268 | 549 |
Roswell Park Memorial Institute Case–control study on bladder cancer [17] | USA | 1957–1965 | Hospital-based case–control | 415 | 138 | 553 | 3,253 | 4,636 | 7,889 |
Reina Sofia University Hospital [18] | Spain | 1997 | Hospital-based case–control | 74 | 11 | 85 | 89 | 41 | 130 |
New Hampshire bladder cancer study [19] | USA | 1994–2001 | Population based case–control | 286 | 104 | 390 | 185 | 138 | 323 |
Italian Case–control study on bladder cancer [20] | Italy | 1985–1993 | Hospital-based case–control | 617 | 110 | 727 | 766 | 298 | 1,064 |
Brescia bladder cancer study [21] | Italy | 1997–2000 | Hospital-based case–control | 200 | 0 | 200 | 214 | 0 | 214 |
Dortmund Hörde study [22] | Germany | 2009–2010 | Hospital based case–control | 145 | 48 | 193 | 177 | 56 | 233 |
National Enhanced Cancer Surveillance System (NESCC) [23] | Canada | 1994–1997 | Population based case–control | 600 | 311 | 911 | 2,451 | 2,423 | 4,874 |
French INSERM study [24] | France | 1984–1987 | Hospital-based case–control | 166 | 33 | 199 | 275 | 47 | 322 |
South and East China Case–control study on bladder and prostate cancer [25] | China | 2005–2008 | Hospital-based case–control | 390 | 93 | 483 | 364 | 100 | 464 |
Molecular Epidemiology of Bladder Cancer and Prostate Cancer [26] | USA | 1993–1997 | Hospital-based case–control | 149 | 45 | 194 | 243 | 58 | 301 |
North Carolina case control study [27] | USA | 1987–1991 | Hospital-based case–control | 188 | 56 | 244 | 174 | 41 | 215 |
Cohort studies | |||||||||
Swedish Mammography Cohort (SMC) & the Cohort of Swedish Men [28] | Sweden | 1987–1990 | Population based cohort | 538 | 119 | 657 | 2,188 | 484 | 2,672 |
Netherlands Cohort Study on diet and cancer [29] | The Netherlands | 1986–2003 | Population based cohort | 779 | 161 | 940 | 2,273 | 2,419 | 4,692 |
Women's Lifestyle and Health Study [30] | Norway, Sweden | 1991–2006 | Population based cohort | 0 | 49 | 49 | 0 | 48,942 | 48,942 |
RERF atomic bomb survivors Study [31] | Japan | 1950–2000 | Population based cohort | 216 | 85 | 301 | 19,362 | 28,249 | 47,611 |
VITamins and Lifestyle Study (VITAL) [32] | USA | 2000–2008 | Population based cohort | 338 | 106 | 444 | 36,454 | 39,983 | 76,437 |
European Prospective Investigation into Cancer and Nutrition (EPIC) [33, 34] | Europe | 1993–2006 | Population based cohort | 1,227 | 525 | 1,752 | 141,872 | 333,279 | 475,151 |
TOTAL | – | – | – | 8,657 | 2,604 | 11,313 | 213,227 | 462,305 | 675,480 |